Morgan Stanley downgrades Lemonade stock rating to Equalweight on valuation
Morgan Stanley has downgraded Lemonade (LMND) to Equalweight from Overweight, citing valuation concerns after the stock's significant rally. This move by a major bank creates a potential short-term pullback opportunity, especially given LMND's history of volatility.
What happened
Morgan Stanley has downgraded Lemonade (LMND) to Equalweight from Overweight, citing valuation concerns after the stock's significant rally.
The read · Jul 8
Morgan Stanley's downgrade of Lemonade (LMND) to Equalweight on valuation raises the question of whether the stock's recent rally is sustainable or due for a correction.
Wrong if
A strong rebound in the broader tech sector or unexpected positive news on profitability could quickly reverse the trend.
CoverageSource: Investing.com · Published here WED, JUL 8 · 3:26 AM ET · the only report in this recordHow this is decided →
The chart · LMNDTradingView · third-party feed, not the Wire’s licensed closes
🔒 Click to interact · scroll moves the page
The story1 min read
Morgan Stanley has revised its rating on Lemonade (LMND) stock, moving it from Overweight to Equalweight. The primary driver behind this downgrade is valuation, following a substantial run-up in LMND's share price over recent months.
Lemonade, an insurance technology company leveraging AI and behavioral economics, has seen its stock gain considerable traction. However, the analyst's view suggests that the current valuation no longer justifies an Overweight rating, implying that much of the near-term upside may already be priced in.
This downgrade comes as LMND reported revenues of $737.9 million, a robust 40.2% year-over-year increase for the fiscal year ending 2025-12-31. Despite strong top-line growth, the company still faces significant profitability challenges, with negative net margins of -22.5% and diluted EPS of -$2.24.
The market reaction to such downgrades can be swift, particularly for growth stocks with high valuations and negative profitability. Traders will be watching to see if this rating change triggers a wave of profit-taking or if the underlying growth narrative continues to support the stock.
The read, in fullWhy it matters
Morgan Stanley's downgrade to Equalweight, specifically citing valuation concerns, suggests that the stock's recent appreciation has outpaced fundamental improvements, especially given its -22.5% net margins and -$2.24 dil. EPS. This provides a tactical short opportunity for profit-taking.
The arc● Open · no developments yet
· Published
The read above, as written. kept as written · closes shown from JUL 8 on
Next · what would move this
1-2 weeks. Follow to be told when one lands.
Since this story · named here, equal weight · 1D EOD-24.8%
JUL 8 · first close after publicationSEP 4
Price context does not establish that the story caused the move.
▲ The case it holds
The bull case for LMND rests on its impressive 40.2% YoY revenue growth, suggesting strong underlying business momentum and market adoption for its insurance technology.
▼ The case it breaks
The bear case is strengthened by Morgan Stanley's downgrade on valuation, highlighting that despite revenue growth, the company's significant negative net margins (-22.5%) and diluted EPS (-$2.24) make its current price unsustainable.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →